Product image of Vyndaqel (Tafamidis) supplied by GNH India

Vyndaqel

Active Ingredient:
Tafamidis
Origin:
EU

Vyndaqel (Tafamidis)

Vyndaqel (tafamidis) is an oral medication used for transthyretin amyloidosis. It helps stabilize transthyretin protein to slow disease progression. This EU-sourced treatment is taken once daily. A trusted option for hereditary transthyretin-mediated amyloidosis management.

Manufacturer / TM Owner

Pfizer Europe Ma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Vyndaqel is prescribed for transthyretin amyloidosis, a condition where abnormal protein builds up and damages organs. It is used to treat adults with hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce symptoms and slow disease progression. This medication is also used for transthyretin amyloidosis polyneuropathy (ATTR-PN) to manage nerve damage. It is not a cure but helps maintain quality of life.

Side Effects

  • Vyndaqel works by stabilizing the transthyretin protein, preventing it from misfolding and forming harmful deposits. Patients may experience reduced symptoms such as fatigue, numbness, or heart-related issues over time. Regular use supports better mobility and daily functioning. Individual responses vary based on disease stage and overall health.

Precautions & Warnings

  • Vyndaqel should be taken exactly as prescribed by a healthcare provider. Inform your doctor about all medications and medical conditions before starting treatment. Regular liver function tests are recommended during therapy. Avoid sudden changes in dosage without medical guidance. Keep this medication stored in a cool, dry place away from direct sunlight.

Avoid Interactions

  • Vyndaqel may interact with medications that affect liver enzymes, such as certain antibiotics or antifungals. Combining it with alcohol or herbal supplements could alter its effectiveness. Always consult a healthcare provider before starting new medications while on Vyndaqel. Inform your doctor about all over-the-counter and prescription drugs to prevent potential interactions.

Frequently Asked Questions

Vyndaqel is used to treat transthyretin amyloidosis, including hereditary transthyretin-mediated amyloidosis (ATTR-CM) and polyneuropathy (ATTR-PN).

Vyndaqel is an oral capsule taken once daily with or without food. Follow your doctor's prescription for proper dosing.

Common side effects may include diarrhea, nausea, or urinary tract infections. Report persistent symptoms to your healthcare provider.

Vyndaqel is available by prescription only. Consult a licensed healthcare provider for a valid prescription before purchasing.

Vyndaqel helps manage symptoms and slow disease progression but is not a cure for transthyretin amyloidosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tafamidis

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT